🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Mimi Najjar

Cleveland Clinic

ORCID: 0009-0007-4609-2157

Also affiliated with Johns Hopkins University, University of Baltimore

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: a phase 2 trial and ctDNA analyses”.

Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: a phase 2 trial and ctDNA analyses

Nature Medicine(2025)10.1038/s41591-025-03958-3

N/A

0.441DataRank · unranked

15 citations

Paul K. Lee, Reza J. Mehran, Chen Hu, Suqi Ke, Amna Jamali +24 more

Poly (ADP-ribose) Polymerase Inhibitor Resistance Driven by Emergence of Polyclonal Mutations With Convergent Evolution: A Molecular Tumor Board Discussion

JCO Precision Oncology(2024)10.1200/po.24.00254

N/A

0.284DataRank · unranked

5 citations

Jaime Wehr, Katerina Karaindrou, Rena R. Xian, Christopher D. Gocke, Ming‐Tseh Lin +35 more

Of Context, Quality, and Complexity: Fine-Combing Tumor Mutational Burden in Immunotherapy-Treated Cancers

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-23-0824

N/A

0DataRank · unranked

8 citations

Mimi Najjar, Colum Dennehy, Ioannis Stouras, Valsamo Anagnostou, Noushin Niknafs